In a stroke cohort with incident hypertension; are more women than men likely to be excluded from recombinant tissue-type Plasminogen Activator (rtPA)?

The treatment outcomes in the use of rt-PA have been reported. Some studies reported worse outcome in women than men, while others presented opposing data. Using data from a hospital-based stroke registry, we investigated evidence of gender difference and determined exclusion criteria in a stroke population with incidence of hypertension.

Source: Journal of the Neurological Sciences - February 7, 2018 Category: Neurology Authors: Jordan Gainey, Leanne Brechtel, Sarah Konklin, Lee Madeline, Lowther Ervin, Brice Blum, Thomas I. Nathaniel Source Type: research